Science and Technology Committee (Lords)

Life Sciences and the Industrial Strategy

Inquiry status: open

The deadline for submissions has now passed. Contact the Clerk if you still wish to make a submission.

Scope of the inquiry

The Committee is conducting an inquiry into Life Sciences and the Industrial Strategy. The UK life sciences sector is high-tech, research-intensive, diverse and innovative. A strong life sciences sector can simultaneously benefit the UK’s economy and help improve the nation’s health. This inquiry will investigate issues such as whether the Government has the necessary structures in place to support the life sciences sector; how the NHS can use procurement to stimulate innovation and the contents of the new life sciences industrial strategy, when published.

The deadline for submissions has now passed; if you still wish to make a submission, please contact the clerk.

Call for evidence

Latest evidence

Next meeting(s)

24 October 2017 10:00 am

Oral Evidence Session

Life Sciences and the Industrial Strategy
View details
Witness(es)

(at 10:10 am)
Mr Keith Chantler, Director of Innovation, Central Manchester University Hospitals NHS Foundation Trust
Dame Julie Moore, Chief Executive, University Hospitals Birmingham NHS Foundation Trust
Professor Bryan Williams, Director of Research, University College London Hospitals NHS Foundation Trust
(at 11:00 am)
Mr Mike Thompson, Chief Executive Officer, Association of the British Pharmaceutical Industry
Ms Nisha Tailor, Head of Policy and Public Affairs, Association of Medical Research Charities
Mr Steve Bates OBE, Chief Executive Officer, BIOINDUSTRY ASSOCIATION
(at 11:50 am)
Professor Sir Robert Lechler FKC, President, Academy of Medical Sciences
Professor Joyce Tait, Director of the Innogen Institute at University of Edinburgh, Royal Society of Edinburgh

Location

Room 4A, Palace of Westminster

Receive RSS updates

Share this page